Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Prices $1B Senior Notes Offering

NEW YORK – Danaher announced Tuesday it has priced an offering of $1 billion of 2.6 percent senior notes due in 2050 at an offering price of 98.97 percent of the principal amount.

The company expects net proceeds to be $980 million after underwriting discounts and offering expenses. Danaher said it will use the money for general corporate purposes, including refinancing of outstanding debts, working capital, and capital expenditures.

The offering is expected to close Oct. 6, subject to customary closing conditions.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.